Dundee partners with Bukwang Pharm to develop new treatment for Parkinson's

(University of Dundee) A multi-million pound partnership will see the University of Dundee partner with the Korean company Bukwang Pharm to develop new drug targets for Parkinson's Disease. The work will see researchers develop drug-like molecules that target an enzyme known to play a role in the progression of the disease.